Read more

December 10, 2020
4 min read
Save

Nearly 10% of transgender hormone users take nonprescription hormones

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Almost one in 10 transgender adults who used hormones had not received a prescription for them, survey data showed. Also, among transgender adults who had insurance, about one in five had an insurance claim for hormones that was denied.

“People who need hormones for gender affirmation may forgo the hormones, along with the opportunity for affirmation and improvement in their mental health and well-being,” Daphna Stroumsa, MD, MPH, a clinical lecturer in obstetrics and gynecology at the University of Michigan School of Medicine, and colleagues wrote.

Of 12,037 transgender individuals who used hormones in 2015, 9.17% used nonprescription hormones
Reference: Stroumsa D, et al. Ann Fam Med. 2020;doi:10.1370/afm.2586.

“Alternatively, if unable to fill a prescription through regulated pathways, transgender people may opt to acquire their medications through other sources; this practice may expose the hormone user to a variety of risks, including toxicity from unregulated substances, incorrect use of medication, and loss of opportunity for medication monitoring and risk mitigation,” the researchers added.

To better understand patterns of nonprescription hormone use and the link between insurance barriers and hormone prescriptions among transgender adults, Stroumsa and colleagues analyzed deidentified data from the 2015 United States Transgender Survey. The results of their analysis, published in Annals of Family Medicine, showed that survey responders (n = 27,715) were disproportionally young, white, highly educated and low income vs. the general U.S. population. Among the 21,237 transgender adults who expressed interest in using hormones, there was “substantial” variation in patterns of hormone use by gender and age, according to the researchers.

“Older age was correlated with a decrease in overall hormone use, as well as use of nonprescription hormones,” Stroumsa and colleagues wrote. “Cultural shifts, along with increasing health concerns, may be at play in explaining this trend.”

According to the researchers, 55.04% of adults who expressed interest in using hormones took them, and of these adults, 9.17% used nonprescription hormones. Among those with insurance, 20.81% had a claim denied. The proportion of the respondents who showed interest in using hormones for gender affirmation did not vary by insurance status (81.27% vs. 83.83%; OR = 1.19; 95% CI, 0.92-1.54), but those who had insurance were more likely to be using hormones than those who lacked insurance (57.4% vs. 41.5%; OR = 2.32; 95% CI, 1.57-3.45).

“It is clear that greater, not lesser, protections of transgender people and their access to care are needed,” Stroumsa and colleagues wrote.